Skip to content

Dexetimide

NERVOUS SYSTEM

Also known as: dexbenzetimide

ATC N04AA08

Data last refreshed: (DrugCentral release 2024-11-01)

Key facts

Dexetimide is a drug catalogued in DrugCentral. DrugCentral lists 3 molecular targets, including CHRM2, Chrm2 and Chrm1|Chrm4|Chrm5|Chrm3|Chrm2. Recorded indications include Neuroleptic-induced Parkinsonism.

  • Molecular targets: CHRM2, Chrm2 and Chrm1|Chrm4|Chrm5|Chrm3|Chrm2 (3 listed in DrugCentral).
  • Indications: Neuroleptic-induced Parkinsonism.
  • ATC code: N04AA08 (Tertiary amines).
  • Molecular formula: C23H26N2O2; molecular weight 362.47 g/mol.

Indications & contraindications

Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).

Indications (1)

  • Neuroleptic-induced Parkinsonism

Mechanism & targets

Molecular targets (3)

TargetGeneActionActivity
Muscarinic acetylcholine receptor M2CHRM2antagonistKi 8.90
Muscarinic acetylcholine receptor M2Chrm2antagonistKi 8.80
Muscarinic acetylcholine receptorChrm1|Chrm4|Chrm5|Chrm3|Chrm2unknownIC50 8.48

ATC classification

ATC codeTherapeutic hierarchy
N04AA08NERVOUS SYSTEM › ANTI-PARKINSON DRUGS › ANTICHOLINERGIC AGENTS › Tertiary amines

Chemical structure

Molecular formulaC23H26N2O2
Molecular weight362.47 g/mol
CAS number21888-98-2
InChIKeyLQQIVYSCPWCSSD-HSZRJFAPSA-N
PubChem CID30843
O=C1CC[C@@](C2CCN(CC3=CC=CC=C3)CC2)(C(=O)N1)C1=CC=CC=C1

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

What is Dexetimide used for?

DrugCentral lists the following indications for Dexetimide: Neuroleptic-induced Parkinsonism.

How does Dexetimide work?

Its molecular targets in DrugCentral include CHRM2 (antagonist), Chrm2 (antagonist) and Chrm1|Chrm4|Chrm5|Chrm3|Chrm2.

What is the chemical formula of Dexetimide?

Dexetimide has the molecular formula C23H26N2O2 and a molecular weight of 362.47 g/mol.

Browse: all drugs starting with D · drug guides by category · protein targets A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.

Quick facts

Status—
First approval—
Agency—
Targets3
Indications1
FormulaC23H26N2O2
DrugCentral ID831
Interactive profile